INSIGHTS

Formulation Development and Clinical Supply of Aseptic Liposomal Formulations

video.svg WEBINAR REPLAY

Drug Product


Casual Nexus Webinar Series - Episode One:


Formulation Development and Clinical Supply of Aseptic Liposomal Formulations


Presenters:
Iain MacGilp, Ph.D., Director, GMP Production, Curia
Amber McFarlane, Head of Formulation Development, Curia

Listen in as our experts discuss:

  • The importance of integrated formulation development and clinical supply function that can support accelerated timelines to the clinic, including complex formulations
  • Recent and ongoing experiences in liposomal formulations, with a focus on high-pressure homogenization
  • Linearity of the laboratory to clinical supply scale-up with supporting analytics
  • Broad applicability to a variety of product types and presentations (liquid, lyophilized, potent compounds, cytotoxics

Want to keep the conversation going? Schedule a meeting with our experts today!


 

 
Block 1
editable text
Block 2 Top
editable text
Block 2 Bottom
editable text
grows to fill column
Block 3 Top
editable text
Block 3 Bottom
editable text
grows to fill column
Block 4
editable text